Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Godkin

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Journal of Clinical Immunology|October 29, 2021
Persistent COVID-19 Infection in Wiskott-Aldrich Syndrome Cleared Following Therapeutic Vaccination: a Case ReportRachel E Bradley, Mark J Ponsford, Martin J Scurr, et al.
Immunology|August 21, 2010
Novel role of regulatory T cells in limiting early neutrophil responses in skinHannah Richards, Anwen Williams, Emma Jones, et al.
The Journal of Allergy and Clinical Immunology|March 22, 2008
Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?Andrew Godkin, Wan Fai Ng, Kathleen Gallagher, et al.
International Journal of Hematology|February 9, 2023
Resolution of persistent SARS-CoV-2 infection with prolonged intravenous remdesivir and vaccination in a patient post CAR-TSai Ambati, Bazga Ali, Owen Seddon, et al.
European Journal of Immunology|February 13, 2007
Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunityAnna Katharina Simon, Emma Jones, Hannah Richards, et al.
Immunotherapy Advances|March 10, 2022
Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexityStephanie E A Burnell, Lorenzo Capitani, Bruce J MacLachlan, et al.
European Journal of Immunology|September 13, 2020
Molecular characterization of HLA class II binding to the LAG-3 T cell co-inhibitory receptorBruce J MacLachlan, Georgina H Mason, Alexander Greenshields-Watson, et al.
Oncoimmunology|May 8, 2015
High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progressionDiana Costa Bento, Emma Jones, Syed Junaid, et al.
Gut|May 14, 2013
The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatmentTom Pembroke, Adam Christian, Emma Jones, et al.
Immunology|December 16, 2014
A distinct chemokine axis does not account for enrichment of Foxp3(+)  CD4(+) T cells in carcinogen-induced fibrosarcomasBeatrice Ondondo, Emily Colbeck, Emma Jones, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Journal of Clinical Immunology|October 29, 2021
Persistent COVID-19 Infection in Wiskott-Aldrich Syndrome Cleared Following Therapeutic Vaccination: a Case ReportRachel E Bradley, Mark J Ponsford, Martin J Scurr, et al.
Immunology|August 21, 2010
Novel role of regulatory T cells in limiting early neutrophil responses in skinHannah Richards, Anwen Williams, Emma Jones, et al.
The Journal of Allergy and Clinical Immunology|March 22, 2008
Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?Andrew Godkin, Wan Fai Ng, Kathleen Gallagher, et al.
International Journal of Hematology|February 9, 2023
Resolution of persistent SARS-CoV-2 infection with prolonged intravenous remdesivir and vaccination in a patient post CAR-TSai Ambati, Bazga Ali, Owen Seddon, et al.
European Journal of Immunology|February 13, 2007
Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunityAnna Katharina Simon, Emma Jones, Hannah Richards, et al.
Immunotherapy Advances|March 10, 2022
Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexityStephanie E A Burnell, Lorenzo Capitani, Bruce J MacLachlan, et al.
European Journal of Immunology|September 13, 2020
Molecular characterization of HLA class II binding to the LAG-3 T cell co-inhibitory receptorBruce J MacLachlan, Georgina H Mason, Alexander Greenshields-Watson, et al.
Oncoimmunology|May 8, 2015
High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progressionDiana Costa Bento, Emma Jones, Syed Junaid, et al.
Gut|May 14, 2013
The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatmentTom Pembroke, Adam Christian, Emma Jones, et al.
Immunology|December 16, 2014
A distinct chemokine axis does not account for enrichment of Foxp3(+)  CD4(+) T cells in carcinogen-induced fibrosarcomasBeatrice Ondondo, Emily Colbeck, Emma Jones, et al.
Pageof 7